Medicare Enrolled

Dr. Johnathan Warminski, MD

Internal Medicine · Southlake, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
305 MORRISON PARK DR STE 100, Southlake, TX 76092
8178656800
In practice since 2009 (16 years)
NPI: 1760618250 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Warminski from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Warminski? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Warminski

Dr. Johnathan Warminski is an internal medicine specialist in Southlake, TX, with 16 years of NPI registration. Based on federal Medicare data, Dr. Warminski performed 65,832 Medicare services across 4,564 unique beneficiaries.

Between the years covered by Open Payments, Dr. Warminski received a total of $4,472 from 26 pharmaceutical and/or device companies across 183 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Warminski is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years in practice ▲ Top 1% volume in TX $4,472 industry payments

Medicare Practice Summary

Medicare Utilization ↗
65,832
Medicare services
Top 1% in TX for internal medicine
4,564
Unique beneficiaries
$53
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~4,114 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Eye injection (Vabysmo/faricimab) 52,049 $29 $50
Comprehensive eye exam, established patient 3,593 $94 $384
Retinal imaging (OCT scan) 3,513 $31 $124
Eye injection for retinal disease 2,236 $97 $415
Aflibercept eye injection (Eylea) 1,411 $685 $1,493
Injection, pegcetacoplan, intravitreal, 1 mg 1,125 $120 $248
Compounded drug, not otherwise classified 746 $75 $177
Comprehensive eye exam, new patient 415 $104 $456
Injection, dexamethasone, intravitreal implant, 0.1 mg 183 $158 $398
Steroid injection (triamcinolone) 152 $1 $3
Retinal photography (fundus photo) 119 $29 $120
Photocoagulation treatment to prevent detachment of retina 53 $178 $1,334
Extended exam of the back part of the eye with retinal drawing 50 $17 $75
Unclassified drugs 39 $1,678 $3,321
Injection of drug or substance into membrane covering eyeball 34 $37 $173
2d ultrasound scan of eye tissue and structures 27 $37 $139
Removal of membrane of retina with removal of internal limiting membrane of retina 23 $901 $3,451
Exam of retinal blood vessels using a special camera after injection of a dye 21 $108 $357
Repair of detached retina with drainage and removal of eye fluid between lens and retina 16 $872 $3,588
Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional 15 $16 $68
New patient office visit, complex (60-74 min) 12 $161 $662
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$4,472
Total received (2018-2024)
Avg $639/year across 7 years
Top 18% in TX for internal medicine
26
Companies
183
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,472 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,864
2023
$1,447
2022
$753
2021
$114
2020
$21
2019
$196
2018
$77

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Regeneron Healthcare Solutions, Inc.
$778
Genentech USA, Inc.
$660
Bausch & Lomb Americas Inc.
$497
Astellas Pharma US Inc
$366
Apellis Pharmaceuticals, Inc.
$350
ABBVIE INC.
$307
AbbVie Inc.
$289
Alimera Sciences, Inc.
$208
Coherus Biosciences Inc.
$200
Sandoz Inc.
$137
Allergan Inc.
$110
EyePoint Pharmaceuticals US, Inc.
$83
Harrow Eye, LLC
$78
Alcon Vision LLC
$62
BioTissue Holdings, Inc.
$46
EYEVANCE PHARMACEUTICALS LLC
$43
TOPCON HEALTHCARE SOLUTIONS, INC.
$40
Bausch & Lomb, a division of Bausch Health US, LLC
$38
ANI Pharmaceuticals, Inc.
$31
Mallinckrodt Hospital Products Inc.
$29
Novartis Pharmaceuticals Corporation
$25
Mallinckrodt Enterprises LLC
$21
Sun Pharmaceutical Industries Inc.
$21
Allergan, Inc.
$18
Eyevance Pharmaceuticals LLC
$17
Avanos Medical
$14
Top 3 companies account for 43.3% of total payments
Associated products mentioned in payments ›
ACTHAR · Cimerli · DEXYCU · DUREZOL · EYLEA · EYLEA HD · IHEEZO · ILUVIEN · Iluvien · Izervay · LOTEMAX SM · Lucentis · ON-Q PUMP AND ACCESSORIES · OZURDEX · PROKERA · PURIFIED CORTROPHIN GEL · Rocklatan · SUSVIMO · Simbrinza · Syfovre · TobraDex ST · VUITY · VYZULTA · Vabysmo · XELPROS · XIPERE · YUTIQ · ZYLET · Zerviate
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $7 per 100 Medicare services performed
Looking for an internal medicine specialist in Southlake?
Compare internal medicine physicians in the Southlake area by procedure volume, costs, and industry payment transparency.
Browse internal medicine physicians nearby

Geographic Context

Internal medicine physicians within 10 mi
2,237
Per 100K population
104.7
County median income
$81,905
Nearest hospital
TEXAS HEALTH HARRIS METHODIST HOSPITAL SOUTHLAKE
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Warminski is a mixed practice specialist, with above-average Medicare volume (top 1% in TX), with low-engagement industry engagement in the top 18% of TX peers, with 16 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Warminski experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Warminski performed 52,049 eye injection (vabysmo/faricimab) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Warminski receive payments from pharmaceutical companies?
Yes. Dr. Warminski received a total of $4,472 from 26 companies across 183 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Warminski's costs compare to other internal medicine physicians in Southlake?
Dr. Warminski's average Medicare payment per service is $53. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Warminski) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →